Oral Kolesterol, AI-Enzymer, Store Biotech Bevegelser

Kilder

• STAT: STAT+: FDA approves Merck’s oral PCSK9 drug, a first
• Nchstats: What Is Lipfendra, the New Pill the FDA Just Approved to Lower Cholesterol Levels? - NCHStats
• Finance: Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia - Yahoo Finance
• GEN: AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells
• Bioengineer: AI designs functional CRISPR-like nucleases surpassing natural models - Bioengineer.org
• GEN: Modular Antibody–ADC Click Chemistry Overcomes Tumor Drug Resistance in Mice - Genetic Engineering and Biotechnology News
• BioSpace: Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
• STAT: STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
• STAT: FDA approves Merck’s oral PCSK9 drug, a first - STAT
• Tradersunion: Eli Lilly to buy AtaiBeckley in up to $3.8bn neuroscience deal - Traders Union
• GEN: Autolomous and Cellular Origins Expand Cell Therapy Manufacturing Process
• GEN: AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells - Genetic Engineering and Biotechnology News
• GEN: See, Blind Mice: Consortium’s Drugs Restore Sight - Genetic Engineering and Biotechnology News
• STAT: STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
• Raps: Recon: Lilly to buy psychedelic developer AtaiBeckley for up to $3.8B; FDA approves Merck’s novel cholesterol drug - RAPS
• STAT: FDA approves Merck’s oral PCSK9 drug, a first - STAT

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.